Prevalence of pyruvate kinase deficiency among the south Iranian population: quantitative assay and molecular analysis.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 17977029)

Published in Blood Cells Mol Dis on October 31, 2007

Authors

M Yavarian1, M Karimi, M Shahriary, A R Afrasiabi

Author Affiliations

1: Hematology Research Center, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran. yavarian@sums.ac.ir

Articles by these authors

Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation (2000) 3.82

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97

Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost (2010) 1.71

Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A (1994) 1.59

Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol (2007) 1.53

Novel THAP1 sequence variants in primary dystonia. Neurology (2010) 1.42

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia (2010) 1.41

Petunia Ap2-like genes and their role in flower and seed development. Plant Cell (2001) 1.31

Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin. Circulation (2001) 1.17

Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire. J Postgrad Med (2008) 1.17

Regulatory sequences of Arabidopsis drive reporter gene expression in nematode feeding structures. Plant Cell (1997) 1.15

Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol (2005) 1.15

Myxoma of the tricuspid valve. J Heart Valve Dis (2000) 1.14

Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation (1994) 1.12

Genes and people in the Caspian Littoral: a population genetic study in Northern Iran. Am J Phys Anthropol (1977) 1.06

Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia (2008) 1.03

Growth hormone deficiency in adults with thalassemia: an overview and the I-CET recommendations. Georgian Med News (2013) 1.02

Renal tubular function in patients with beta-thalassaemia major in Zahedan, southeast Iran. Singapore Med J (2008) 1.00

Beta-globin gene cluster haplotypes in sickle cell patients from southwest Iran. Am J Hematol (2003) 0.93

Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol (2012) 0.91

Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial. Stroke Res Treat (2011) 0.89

Endocrine function in thalassemia intermedia. Int J Biomed Sci (2006) 0.89

Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease. J Neurol Neurosurg Psychiatry (2011) 0.88

Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). J Thromb Haemost (2008) 0.86

Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson's disease. Exp Neurol (2012) 0.86

Bone mineral density in Iranian patients with haemophilia: the first experience in southern Iran. Haemophilia (2011) 0.85

Initial presentation of acute lymphoblastic leukemia with osteoporosis and multiple spontaneous bone fractures. Iran Red Crescent Med J (2011) 0.84

Epidemiology of tuberculosis among Afghan immigrants in Fars province, southern Islamic Republic of Iran. East Mediterr Health J (2007) 0.84

Mass trivalent oral polio vaccination in primary school age children in Teheran. Trop Geogr Med (1970) 0.83

Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency. Haemophilia (2008) 0.82

The impact of educating parents of leukemic children on the patients' quality of life. Iran Red Crescent Med J (2011) 0.82

The CD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma. J Pathol (2008) 0.81

Vitrification of in vitro produced ovine embryos at various developmental stages using two methods. Cryobiology (2009) 0.81

A novel single step double positive double negative selection strategy for beta-globin gene replacement. Biochem Biophys Res Commun (2006) 0.81

Molecular characterization of a novel amastigote stage specific Class I nuclease from Leishmania major. Int J Parasitol (2004) 0.81

Home therapy and the effect of educational programmes in Iran; an alternative treatment option in developing countries. Haemophilia (2009) 0.80

Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia (2011) 0.80

International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow. Georgian Med News (2012) 0.80

Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost (2004) 0.80

Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran. Platelets (2007) 0.80

Health status in Iranian haemophilic patients. Haemophilia (2008) 0.79

Renal transplantation: levels of prolactin, leutinizing hormone, follicle-stimulating hormone and testosterone. Transplant Proc (1999) 0.78

MRI evaluation of liver iron concentration in patients with β-thalassemia major. Hepat Mon (2011) 0.78

Activation of a pollenin promoter upon nematode infection. J Nematol (2002) 0.78

Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int J Lab Hematol (2008) 0.78

Quality of life in hemophilia complicated by inhibitors. Iran Red Crescent Med J (2012) 0.78

Attitudes and practices with regard to circumcision in haemophilia patients in Southern Iran. Haemophilia (2013) 0.77

Maternal and prenatal risk factors for childhood leukemia in southern of iran. Iran Red Crescent Med J (2011) 0.77

The burden and management of FXIII deficiency. Haemophilia (2014) 0.77

Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran. Haemophilia (2009) 0.77

Analysis of nematode-responsive promoters in sugar beet hairy roots. Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet (2001) 0.76

Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources. Transfus Med (2015) 0.76

Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran. Clin Lab Haematol (2005) 0.76

Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot study. AJR Am J Roentgenol (2009) 0.76

Mutation analysis in F9 gene of 17 families with haemophilia B from Iran. Haemophilia (2004) 0.76

Combined α-thalassemia and Hemoglobin J-Iran (β77 His → Asp). A Family Study in southern Iran. Iran Red Crescent Med J (2011) 0.75

Successful Management of Vinblastin Overdose with Exchange Transfusion: A Case Report. Iran J Ped Hematol Oncol (2015) 0.75

Ordering and growth of rare gas films (Xe, Kr, Ar, and Ne) on the pseudo-ten-fold quasicrystalline approximant Al₁₃Co₄(100) surface. J Phys Condens Matter (2014) 0.75

Frequency of afterload homocysteinemia in normal population of Southern Iran: a pilot study. Pak J Biol Sci (2010) 0.75

Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran. J Thromb Haemost (2006) 0.75

Forecasting of daily total atmospheric ozone in Isfahan. Environ Monit Assess (2008) 0.75

Evaluation of the FXIII deficiency prophylaxis intervals in large number of FXIII deficiency patients from Iran. Haemophilia (2013) 0.75

D-dimer level in pediatric patients with solid and hematologic malignancies, Shiraz, Southern Iran. Int J Lab Hematol (2011) 0.75

An experience of using Traumastem P in control of spontaneous nose bleeding in patients with inherited bleeding disorders in southern Iran. Haemophilia (2013) 0.75

The self-trapping attractor neural network. I. Analysis of a simple 1-D model. IEEE Trans Neural Netw (2003) 0.75

Assessment of annual effective dose from 238U and 226Ra due to consumption of foodstuffs by inhabitants of Tehran city, Iran. Radiat Prot Dosimetry (2006) 0.75

Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia (2012) 0.75

Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders. Haemophilia (2012) 0.75

Allele frequency of CYP2C9 gene polymorphisms in Iran. Thromb Haemost (2002) 0.75

The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran. Haemophilia (2011) 0.75

Lipid profile in Africans with renal failure. East Afr Med J (1979) 0.75

Subclassification of localized Leishmania lymphadenitis in fine needle aspiration smears. Acta Cytol (2001) 0.75

Multiple myeloma in Kenyan Africans - a prospective study. East Afr Med J (1981) 0.75

Attitudes of haemophilic patients towards their health and socio-economic problems in Iran. Haemophilia (2011) 0.75

The cytoskeleton in nematode feeding sites. Commun Agric Appl Biol Sci (2003) 0.75

Effect of L-carnitine supplementation in comparison with moderate aerobic training on serum inflammatory parameters in healthy obese women. J Sports Med Phys Fitness (2015) 0.75

Inhibitors to factor VII in congenital factor VII deficiency. Haemophilia (2014) 0.75

Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran. Transfus Med (2011) 0.75

Polymorphisms associated with sickle cell disease in Southern Iran. Genetika (2012) 0.75

Use of gelatin-acacia coacervate containing benzocaine in topical formulations. J Pharm Sci (1999) 0.75